Quantum Cyber vs YD Bio
QUCY and YDES side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How QUCY and YDES compare
YD Bio scores higher on the StockData Score (5 against 1 for Quantum Cyber), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | QUCY | YDES |
|---|---|---|
| Size and price | ||
| Share price | $0.560 | $4.88 |
| Change, 1 year | −56.9% | −44.8% |
| Change, 5 years | −94.3% | −52.0% |
| Beta (5Y) | 2.68 | 0.10 |
| Employees | 3 | 13 |
| StockData Score | ||
| Total score | 1 | 5 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | – | 16.9% |
| Revenue growth, 5Y average | 1.7% | – |
| Profitability | ||
| Gross margin | – | 28.1% |
| Operating margin | – | −883% |
| Net margin | – | −1393% |
| FCF margin | – | −1347% |
| Return on equity | −237% | −174% (better) |
| Return on invested capital | −369% | −130% (better) |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −104.9× | – |
| Current ratio | 3.73 | 5.23 (better) |
| Piotroski F-score | 2 | 2 |
| Ownership | ||
| Held by institutions | 0.27% | – |
| Held by insiders | – | 92.8% |
| Insider net buying, 12 months | $0 | $129K (better) |
Go deeper
- QUCY stock overview
- QUCY income statement
- QUCY valuation and score
- YDES stock overview
- YDES income statement
- YDES valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.